Types of Research
- (-) Remove Aid & Other Development Finance filter Aid & Other Development Finance
- (-) Remove Research & Development filter Research & Development
In many countries in Sub-Saharan Africa and South Asia smallholder farmers are among the most vulnerable to climatic changes, and the observed shocks and stresses associated with these changes impact agricultural systems in many ways. This research brief offers findings on observed or measured changes in precipitation, temperature or both, on five biophysical pathways and systems including variable or changing growing seasons, extreme events, biotic stressors, plant species density, richness and range, impacts to streamflow, and impacts on crop yield. These findings are the result of a review of relevant documents cited in Kilroy (2015), references included in the IPCC draft Special Report on Food Security, and targeted searches from 2015 - present for South Asia and Sub-Saharan Africa.
The private sector is the primary investor in health research and development (R&D) worldwide, with investment annual investment exceeding $150 billion, although only an estimated $5.9 billion is focused on diseases that primarily affect low and middle-income countries (LMICs) (West et al., 2017b). Pharmaceutical companies are the largest source of private spending on global health R&D focused on LMICs, providing $5.6 billion of the $5.9 billion in total private global health R&D per year. This report draws on 10-K forms filed by Pharmaceutical companies with the U.S. Securities and Exchange Commission (SEC) in the year 2016 to examine the evidence for five specific disincentives to private sector investment in drugs, vaccines and therapeutics for global health R&D: scientific uncertainty, weak policy environments, limited revenues and market uncertainty, high fixed costs for research and manufacturing, and imperfect markets. 10-K reports follow a standard format, including a business section and a risk section which include information on financial performance, investment options, lines of research, promising acquisitions and risk factors (scientific, market, and regulatory). As a result, these filings provide a valuable source of information for analyzing how private companies discuss risks and challenges as well as opportunities associated with global health R&D targeting LMICs.
Crop yield is one of the most commonly used partial factor productivity measures. It is used to estimate the ratio of quantity of crop output, generally measured in kilograms or tons, to a sole input, land area. Ongoing EPAR research explores the policy implications of measuring yield by area planted versus area harvested. In this brief, we consider implications for crop yield estimates of other decisions in how to construct yield measures from household survey microdata. Using data from three waves of the Tanzania National Panel Survey (TNPS) and two waves of the Ethiopia Socioeconomic Survey (ESS), both part of the World Bank’s Living Standards Measurement Study-Integrated Surveys on Agriculture (LSMS-ISA), we calculate separate crop yield estimates across survey waves following different decisions on disaggregating yield by gender(s) of the plot decision-maker(s) and for pure-stand and mixed stand (intercropped) plots, on including crop production from multiple growing seasons, and on how to treat outlier observations.
An ongoing stream of EPAR research considers how public good characteristics of different types of research and development (R&D) and the motivations of different providers of R&D funding affect the relative advantages of alternative funding sources. For this project, we seek to summarize the key public good characteristics of R&D investment for agriculture in general and for different subsets of crops, and hypothesize how these characteristics might be expected to affect public, private, or philanthropic funders’ investment decisions.